| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Divisions of Endocrine Research (M.A.A., M.L.H., F.T., D.P.S., H.M.H.), Research Technologies and Proteins (A.K., E.G., N.F.), and Gene Regulation, Bone and Inflammatory Diseases (Y.L.M.), Eli Lilly and Co., Indianapolis, Indiana 46285; Eli Lilly and Company, Bad Homburg D-61350, Germany; and University Childrens Hospital (W.F.B.), Giessen D-35392, Germany
Address all correspondence and requests for reprints to: Hansen M. Hsiung, Ph.D., Endocrine Research, DC0424 Lilly Corporate Center, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285. E-mail: hsiung_hansen_m{at}lilly.com.
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) are two closely related peptides that bind two homologous G protein-coupled receptors, VIP/PACAP receptor 1 (VPAC1R) and VIP/PACAP receptor II (VPAC2R), with equally high affinity. Recent reports suggest that VPAC2R plays a role in circadian rhythm and T cell functions. To further elucidate the functional activities of VPAC2R, we generated VPAC2R-deficient mice by deleting exons VIIIX of the VPAC2R gene. The VPAC2R-deficient mice showed retarded growth and had reduced serum IGF-I levels compared with gender-matched, wild-type siblings. The mutant mice appeared healthy and fertile at a young adult age. However, older male mutant mice exhibited diffuse seminiferous tubular degeneration with hypospermia and reduced fertility rate. The mutant mice appeared to have an increase in insulin sensitivity. VPAC2R-deficient mice had increased lean mass and decreased fat mass with reduced serum leptin levels. Indirect calorimetry experiments showed that the respiratory quotient values immediately following the transition into the dark cycle were significantly higher in male knockout mice for about 4 h. Additionally, male and female VPAC2R-deficient mice presented an increased basal metabolic rate (23% and 10%, respectively) compared with their wild-type siblings. Our results suggest that VPAC2R plays an important role in growth, basal energy expenditure, and male reproductive functions.
This article has been cited by other articles:
![]() |
A.T.L. Hughes and H.D. Piggins Behavioral Responses of Vipr2-/- Mice to Light J Biol Rhythms, June 1, 2008; 23(3): 211 - 219. [Abstract] [PDF] |
||||
![]() |
B. A. Adams, S. L. Gray, E. R. Isaac, A. C. Bianco, A. J. Vidal-Puig, and N. M. Sherwood Feeding and Metabolism in Mice Lacking Pituitary Adenylate Cyclase-Activating Polypeptide Endocrinology, April 1, 2008; 149(4): 1571 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lacombe, V. Lelievre, C. E Roselli, J.-M. Muller, J. A Waschek, and E. Vilain Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis J. Endocrinol., July 1, 2007; 194(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahren, N. Wierup, and F. Sundler Neuropeptides and the Regulation of Islet Function Diabetes, December 1, 2006; 55(Supplement_2): S98 - S107. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dolatshad, E.A. Campbell, L. O'Hara, E.S. Maywood, M.H. Hastings, and M.H. Johnson Developmental and reproductive performance in circadian mutant mice Hum. Reprod., January 1, 2006; 21(1): 68 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koster, Y. B. Chao, M. Mosior, A. Ford, P. A. Gonzalez-DeWhitt, J. E. Hale, D. Li, Y. Qiu, C. C. Fraser, D. D. Yang, et al. Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism Endocrinology, November 1, 2005; 146(11): 4943 - 4950. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Hinkle, E. Donnelly, D. B. Cody, R. J. Sheldon, and R. J. Isfort Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force J Appl Physiol, February 1, 2005; 98(2): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Akesson, B. Ahren, G. Edgren, and E. Degerman VPAC2-R Mediates the Lipolytic Effects of Pituitary Adenylate Cyclase-Activating Polypeptide/Vasoactive Intestinal Polypeptide in Primary Rat Adipocytes Endocrinology, February 1, 2005; 146(2): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Otto, L. Hein, M. Brede, R. Jahns, S. Engelhardt, H.-J. Grone, and G. Schutz Pulmonary Hypertension and Right Heart Failure in Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor-Deficient Mice Circulation, November 16, 2004; 110(20): 3245 - 3251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srinivasan, D. O. Bunch, Y. Feng, R. M. Rodriguiz, M. Li, R. L. Ravenell, G. X. Luo, A. Arimura, L. D. Fricker, E. M. Eddy, et al. Deficits in Reproduction and Pro-Gonadotropin-Releasing Hormone Processing in Male Cpefat Mice Endocrinology, April 1, 2004; 145(4): 2023 - 2034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |